42 results
6-K
HUGE
FSD Pharma Inc - Ordinary Shares
21 Feb 24
Current report (foreign)
8:46pm
. The Corporation defended the arbitration and counterclaimed against Dr. Bokhari for reimbursement of expenses he directed the Corporation to pay
6-K
EX-10.1
HUGE
FSD Pharma Inc - Ordinary Shares
20 Feb 24
FSD Pharma Announces US ATM Offering
6:01am
for (i) payment of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other
424B5
HUGE
FSD Pharma Inc - Ordinary Shares
16 Feb 24
Prospectus supplement for primary offering
6:36pm
and excise taxes;
uncertainty associated with insurance coverage and reimbursement status for newly-approved pharmaceutical products, which could result … in Product Candidates becoming subject to unfavorable pricing regulations, third-party coverage and reimbursement practices, or healthcare reform
F-3
f2is70z1d
22 Dec 23
Shelf registration (foreign)
6:49pm
6-K
EX-99.2
eljg3j6
14 Nov 22
Condensed consolidated interim financial statements
6:02am
6-K
EX-99.2
ghboft5hq8h mnn7nv
12 Aug 22
Condensed consolidated interim financial statements
4:58pm
6-K
EX-99.1
wzw7hpm
23 May 22
Annual General Meeting of the Shareholders
4:29pm
6-K
EX-99.2
6s1prqqcigk fnn
13 May 22
Condensed consolidated interim financial statements
5:10pm
20-F
EX-4.15
btkwa5
31 Mar 22
Annual report (foreign)
8:09am
20-F
hliri j68p90
31 Mar 22
Annual report (foreign)
8:09am
20-F
EX-4.16
vl2lqz
31 Mar 22
Annual report (foreign)
8:09am
20-F
EX-4.17
jt2p i0nl9kpezqz
31 Mar 22
Annual report (foreign)
8:09am
20-F
EX-15.1
7btx3 zuw
31 Mar 22
Annual report (foreign)
8:09am
20-F
EX-4.14
5noj18hv zc8ibay5i
31 Mar 22
Annual report (foreign)
8:09am